Thinly traded nano cap Applied DNA Sciences (NASDAQ:APDN) is the latest company to jump on the coronavirus bandwagon. Shares are up 70% premarket on increased volume on the heels of its announcement
that four DNA vaccine candidates will be produced for preclinical
testing using its proprietary PCR-based DNA manufacturing systems.
Majority-owned subsidiary LineaRx will develop the candidates, including one against COVID-19, with Takis Biotech.
https://seekingalpha.com/news/3547323-applied-dna-sciences-up-70-premarket-on-coronavirus-vaccine-plan
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.